Faecal microbiota transplantation versus placebo for moderate-to-severe irritable bowel syndrome: a double-blind, randomised, placebo-controlled, parallel-group, single-centre trial

The Lancet. Gastroenterology & Hepatology
Peter Holger JohnsenRasmus Goll

Abstract

Irritable bowel syndrome (IBS) is a common condition characterised by abdominal pain, bloating, and poor quality of life. IBS might be caused by a gut dysbiosis. We aimed to compare faecal microbiota transplantation (FMT) with placebo in patients with IBS. In this double-blind, randomised, placebo-controlled, parallel-group, single-centre study, we enrolled patients with IBS with diarrhoea or with diarrhoea and constipation (excluding dominating constipation) defined by the ROME III criteria, scored as moderate to severe according to the IBS severity scoring system (IBS-SSS; a score of ≥175). Eligible participants were aged 18-75 years and were recruited locally by general practitioners in northern Norway. We randomly assigned participants (2:1) in blocks of six to active or placebo FMT. Personnel not involved in the clinical performance of the trial generated the randomisation sequence using a randomisation website. Non-study personnel performed the final allocation and standardised the active and placebo transplants to make them identical in appearance and temperature. The faeces were freshly processed, and were used the same day (fresh transplant) or were stored in a freezer for later use (frozen transplant); participants' o...Continue Reading

Citations

Mar 3, 2018·Advances in Therapy·Bruno K Rodiño-JaneiroJavier Santos
Apr 26, 2018·Annals of Nutrition & Metabolism·Paul Enck, Nazar Mazurak
Jul 4, 2018·Journal of Neurogastroenterology and Motility·Hirokazu FukuiHiroto Miwa
Jun 26, 2018·Current Opinion in Clinical Nutrition and Metabolic Care·Sonia Bouri, Ailsa Hart
Oct 20, 2018·Current Opinion in Gastroenterology·Pete Dayananda, Mark H Wilcox
Nov 8, 2018·Annual Review of Medicine·R E OoijevaarJ J Keller
Dec 13, 2018·Journal of Pediatric Gastroenterology and Nutrition·Zev H DavidovicsUNKNOWN FMT Special Interest Group of the North American Society of Pediatric Gastroenterology Hepatology, Nutrition, the European S
Mar 9, 2019·The Kaohsiung Journal of Medical Sciences·Chieh-Chang ChenUNKNOWN Taiwan Gastrointestinal Disease and Helicobacter Consortium
Mar 27, 2019·Clinical Endoscopy·Kyeong Ok Kim, Michael Gluck
May 28, 2019·Nutrients·Jessica R BiesiekierskiHeidi M Staudacher
Mar 26, 2019·The American Journal of Gastroenterology·Dabo XuChung Owyang
Jul 23, 2019·Journal of Neurogastroenterology and Motility·Sudhir K DuttaPadmanabhan P Nair
Aug 29, 2019·Physiological Reviews·John F CryanTimothy G Dinan
Nov 23, 2019·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·Jordi SerraUNKNOWN Functional Constipation Guidelines Working Group
Dec 4, 2019·Current Opinion in Endocrinology, Diabetes, and Obesity·Andrew CanakisHorst Christian Weber
Jan 21, 2020·The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics·Pilar N Ossorio, Yao Zhou
Jun 7, 2019·Current Opinion in Pediatrics·Bhaskar Gurram, Paul K Sue
Nov 30, 2019·The Kaohsiung Journal of Medical Sciences·Charles C HerndonChing-Liang Lu
Apr 12, 2020·Nutrients·Guillaume B FondLaurent Boyer
Feb 28, 2020·Gut·Giovanni Barbara, Gianluca Ianiro
Oct 2, 2019·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Jing MaShuixiang He
May 14, 2020·Microorganisms·Georgios TziatziosKonstantinos Triantafyllou
Apr 25, 2018·European Journal of Gastroenterology & Hepatology·Umair IqbalMuhammad A Karim
Jul 14, 2020·Alimentary Pharmacology & Therapeutics·Perttu LahtinenPerttu Arkkila
Apr 25, 2018·Protein & Cell·Faming ZhangUNKNOWN FMT-standardization Study Group
Feb 6, 2019·Case Reports in Gastrointestinal Medicine·Igor Alexander Harsch, Peter Christopher Konturek
Jan 17, 2019·European Heart Journal·Allan Davies, Thomas F Lüscher
Jun 30, 2019·The Proceedings of the Nutrition Society·Marion Rincel, Muriel Darnaudéry
Oct 31, 2019·United European Gastroenterology Journal·Kanchana MyneeduMohammad Bashashati
Aug 31, 2019·BioMed Research International·Youlian ZhouYuqiang Nie
Aug 28, 2020·Alimentary Pharmacology & Therapeutics·Perttu LahtinenPerttu Arkkila
Oct 6, 2020·Frontiers in Cellular and Infection Microbiology·Caterina CarcoNicole C Roy

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacteriotherapy (ASM)

Bacteriotherapy, also known as fecal transplantation, involves the transfer of stool from a healthy donor into the gastrointestinal tract for the purpose of treating recurrent C. difficile colitis. Here is the latest on bacteriotherapy.

Bacteriotherapy

Bacteriotherapy, also known as fecal transplantation, involves the transfer of stool from a healthy donor into the gastrointestinal tract for the purpose of treating recurrent C. difficile colitis. Here is the latest on bacteriotherapy.